Company Overview

TRANSMEDICS GROUP, INC.

TMDX
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
605M
2025 FY
Net Income
190M
2025 FY
Shares Outstanding
34M
2025 FY
EPS
5.6USD
2025 FY
Company Information
SIC Code
3845
CIK Code
1756262
Exchange
Nasdaq
Location
US